Multiple Myeloma Resources
Chosen by Advanced
Practice Providers
  • Clinical guidelines
  • Patient support and education resources
  • Research updates

Study Highlights High Early Mortality in Multiple Myeloma, Especially Among Older, Male, and Minority Patients

Early mortality (EM) is a concern in hematologic malignancies, including multiple myeloma (MM), where mortality rates remain high within the first two years of diagnosis. Despite advances in...
CURATED BY: Danielle Roberts,
MS, MMSc, PA-C

Supportive Care Key to Managing Side Effects in Multiple Myeloma

Multiple myeloma (MM) is the second most common hematologic malignancy in the United States. Advances in treatments such as proteasome inhibitors, immunomodulatory drugs, monoclonal antibodies, and stem cell transplants have...
CURATED BY:
Laura J. Zitella,
MS, RN, ACNP-BC, AOCN

CAR T-Cell Therapy Offers Hope for Relapsed Multiple Myeloma

Multiple myeloma (MM) impacts around 35,000 new patients annually in the United States, with over 12,000 deaths. Advances in treatments like proteasome inhibitors, immunomodulatory drugs, and monoclonal antibodies have improved...
CURATED BY:
Laura J. Zitella,
MS, RN, ACNP-BC, AOCN

Rare Multiple Myeloma Case in Pregnancy Successfully Managed With Treatment, Leading to Healthy Delivery

Multiple myeloma (MM) during pregnancy is rare, with only 45 cases reported between 1965 and 2020. In the presented case, a 40-year-old woman was diagnosed with oligosecretory IgG kappa MM...
CURATED BY:
Jill N. Burke,
CNP, DipACLM

Physician Associate and Nurse Practitioner Contributors to the Multiple Myeloma Center of Excellence

POCN’s Multiple Myeloma Center of Excellence is curated by practicing clinical physician associates and nurse practitioners who review and select resources that are the most useful to their peers. They provide their expertise by hand-picking the latest content for advanced practice providers.

Provided by an unrestricted grant from

Share